H
HUTCHMED (China) Ltd
HKEX:13
HUTCHMED (China) Ltd
HKEX:13
Price:
21.5
HKD
2.63%
Market Closed
Market Cap:
18.7B
HKD
Balance Sheet
Balance Sheet Decomposition
HUTCHMED (China) Ltd
HUTCHMED (China) Ltd
| Current Assets | 1B |
| Cash & Short-Term Investments | 802.5m |
| Receivables | 192.3m |
| Other Current Assets | 53.5m |
| Non-Current Assets | 212.6m |
| Long-Term Investments | 80.5m |
| PP&E | 94.8m |
| Other Non-Current Assets | 37.3m |
Balance Sheet
HUTCHMED (China) Ltd
HUTCHMED (China) Ltd
Currency: USD
Millions
Annual
| Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
47
|
39
|
32
|
79
|
85
|
86
|
121
|
236
|
378
|
313
|
|
| Cash |
0
|
0
|
32
|
31
|
30
|
79
|
86
|
88
|
105
|
178
|
|
| Cash Equivalents |
47
|
39
|
0
|
48
|
55
|
7
|
35
|
148
|
273
|
135
|
|
| Short-Term Investments |
0
|
12
|
0
|
25
|
274
|
215
|
97
|
201
|
635
|
319
|
|
| Total Receivables |
15
|
36
|
46
|
49
|
59
|
57
|
79
|
67
|
149
|
129
|
|
| Accounts Receivables |
13
|
34
|
35
|
45
|
42
|
43
|
43
|
47
|
82
|
98
|
|
| Other Receivables |
2
|
2
|
11
|
4
|
16
|
14
|
36
|
20
|
67
|
31
|
|
| Inventory |
1
|
4
|
10
|
13
|
12
|
12
|
16
|
20
|
36
|
57
|
|
| Other Current Assets |
3
|
3
|
1
|
1
|
3
|
0
|
4
|
7
|
14
|
22
|
|
| Total Current Assets |
67
|
94
|
90
|
167
|
432
|
371
|
317
|
531
|
1 212
|
840
|
|
| PP&E Net |
7
|
9
|
10
|
11
|
15
|
18
|
27
|
32
|
53
|
85
|
|
| PP&E Gross |
7
|
9
|
10
|
11
|
15
|
18
|
27
|
32
|
53
|
85
|
|
| Accumulated Depreciation |
12
|
13
|
14
|
15
|
17
|
20
|
23
|
26
|
33
|
37
|
|
| Intangible Assets |
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Goodwill |
0
|
2
|
3
|
3
|
3
|
3
|
3
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
16
|
0
|
0
|
0
|
|
| Long-Term Investments |
111
|
113
|
120
|
159
|
144
|
138
|
99
|
140
|
76
|
74
|
|
| Other Long-Term Assets |
0
|
0
|
7
|
2
|
2
|
2
|
2
|
22
|
31
|
31
|
|
| Other Assets |
0
|
2
|
3
|
3
|
3
|
3
|
3
|
0
|
0
|
0
|
|
| Total Assets |
186
N/A
|
219
+18%
|
230
+5%
|
342
+49%
|
598
+75%
|
532
-11%
|
465
-13%
|
724
+56%
|
1 373
+90%
|
1 029
-25%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
4
|
20
|
24
|
36
|
24
|
26
|
24
|
32
|
41
|
71
|
|
| Accrued Liabilities |
8
|
7
|
21
|
27
|
33
|
48
|
74
|
111
|
194
|
246
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
52
|
26
|
23
|
20
|
30
|
0
|
3
|
3
|
27
|
0
|
|
| Other Current Liabilities |
14
|
15
|
13
|
12
|
16
|
11
|
12
|
13
|
50
|
37
|
|
| Total Current Liabilities |
78
|
69
|
81
|
95
|
105
|
85
|
113
|
158
|
312
|
354
|
|
| Long-Term Debt |
0
|
27
|
27
|
27
|
0
|
27
|
30
|
33
|
7
|
23
|
|
| Deferred Income Tax |
2
|
3
|
3
|
4
|
4
|
5
|
3
|
5
|
3
|
3
|
|
| Minority Interest |
16
|
25
|
19
|
20
|
23
|
23
|
25
|
35
|
53
|
27
|
|
| Other Liabilities |
0
|
0
|
16
|
12
|
4
|
3
|
6
|
9
|
12
|
13
|
|
| Total Liabilities |
97
N/A
|
124
+28%
|
146
+18%
|
158
+8%
|
136
-14%
|
143
+5%
|
177
+24%
|
240
+36%
|
386
+61%
|
419
+9%
|
|
| Equity | |||||||||||
| Common Stock |
52
|
53
|
57
|
61
|
66
|
67
|
67
|
73
|
86
|
86
|
|
| Retained Earnings |
69
|
66
|
92
|
80
|
107
|
183
|
290
|
416
|
610
|
971
|
|
| Additional Paid In Capital |
94
|
98
|
114
|
208
|
497
|
506
|
515
|
822
|
1 505
|
1 497
|
|
| Other Equity |
12
|
10
|
5
|
4
|
5
|
0
|
4
|
4
|
6
|
2
|
|
| Total Equity |
89
N/A
|
95
+7%
|
83
-12%
|
184
+121%
|
462
+151%
|
389
-16%
|
288
-26%
|
484
+68%
|
987
+104%
|
610
-38%
|
|
| Total Liabilities & Equity |
186
N/A
|
219
+18%
|
230
+5%
|
342
+49%
|
598
+75%
|
532
-11%
|
465
-13%
|
724
+56%
|
1 373
+90%
|
1 029
-25%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
521
|
531
|
565
|
607
|
664
|
667
|
667
|
728
|
865
|
865
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
